Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2025 Earnings Call Transcript April 29, 2025
Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.01 EPS, expectations were $-0.99.
Operator: Good afternoon. Welcome to Sage Therapeutics First Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors and Media section of Sage’s website at sagerx.com. This call is the property of Sage Therapeutics and recording,...
